Drug target · CNR1
CB1
Cannabinoid receptor 1
2 compounds in the CNS pipeline act on CB1.
Compounds targeting CB1
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| AEF0117 (lixosicone)primarySmall molecule | NAM | — | Phase 2Cannabis use disorder | Aelis Farma S.A. |
| AEF0217primarySmall molecule | NAM | — | Phase 2Down Syndrome | Aelis Farma S.A. |